share_log

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND RAISES 2024 CAPLYTA SALES GUIDANCE

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND RAISES 2024 CAPLYTA SALES GUIDANCE

Intra-Cellular Therapies | 8-K:细胞内疗法公布了2024年第三季度财务业绩,提供了公司最新情况,并提高了2024年的CAPLYTA销售指导
美股SEC公告 ·  2024/10/30 19:47
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息